Get started
Author

Pedro Bedate Díaz

Observed names: P Bedate Diaz, Pedro Bedate, Pedro Bedate Diaz, Pedro Bedate-Diaz
ORCID: 0000-0002-0768-4113
Observed ORCID: 0000-0002-0768-4113
OpenAlex ID: A5102925803
Assessment of risk scores in Covid‐19
2020 · Marta María García Clemente, Julia Herrero Huertas, et al. · International Journal of Clinical Practice · 41
PDF
Impact of interstitial lung disease on the survival of systemic sclerosis with pulmonary arterial hypertension
2022 · Alfredo Guillén-Del-Castillo, Manuel López Meseguer, et al. · Scientific Reports · 26
Real-life experience of inhaled iloprost for patients with pulmonary arterial hypertension: Insights from the Spanish REHAP registry
2018 · Roberto Del Pozo, Isabel Blanco, et al. · International Journal of Cardiology · 15
From Health-Related Quality of Life (HRQoL) of Patients with Pulmonary Hypertension to Patient Experience with the Care Received: Should We Be More Aware of Current Patient Needs?
2021 · Amaya Martínez Meñaca, Isabel Blanco Vich, et al. · Advances in Therapy · 8
Changes in REVEAL risk score in patients with pulmonary arterial hypertension treated with macitentan in clinical practice: results from the PRACMA study
2020 · Pilar Escribano-Subias, Raquel López, et al. · BMC Pulmonary Medicine · 7
PDF
Correlation between short-term air pollution exposure and unprovoked lung embolism. Prospective observational (Contamina-TEP Group)
2020 · Javier de Miguel-Diez, Isabel Blasco-Esquivias, et al. · Thrombosis Research · 7
Evolution of Patients with Pulmonary Arterial Hypertension Starting Macitentan After the Discontinuation of Other Endothelin-Receptor Antagonists: Results of a Retrospective Study
2019 · Sergio Cadenas-Menéndez, Pablo Álvarez Vega, et al. · American Journal of Cardiovascular Drugs · 7
Risk Stratification in Pulmonary Veno-Occlusive Disease
2024 · Alejandro Cruz-Utrilla, Carmen Pérez-Olivares, et al. · Archivos de Bronconeumología · 3
Utilidad de la genética en la reclasificación y la mejoría en la estratificación pronóstica en la hipertensión arterial pulmonar
2023 · Alejandro Cruz-Utrilla, Natalia Gallego-Zazo, et al. · Revista Española de Cardiología · 3
Usefulness of genetics for clinical reclassification and refinement of prognostic stratification in pulmonary arterial hypertension
2022 · Alejandro Cruz-Utrilla, Natalia Gallego-Zazo, et al. · Revista Española de Cardiología (English Edition) · 3
Author Correction: Impact of interstitial lung disease on the survival of systemic sclerosis with pulmonary arterial hypertension
2022 · Alfredo Guillén-Del-Castillo, Manuel López Meseguer, et al. · Scientific Reports · 3
PDF
Correlation between perceived quality of life among patients with Pulmonary Arterial Hypertension, the 6-minute walking test and the risk stratification
2019 · Amaya Martinez Meñaca, Ines Fernandez-Cuesta Peñafiel, et al. · European Respiratory Journal · 1
4. Aplicabilidad De La Escala Estratificación Pronóstica Europea Al Diagnóstico En La Enfermedad Venooclusiva Pulmonar
2023 · Carmen Pérez Olivares Delgado, Alejandro Cruz Utrilla, et al. · Revista Española de Cardiología
Impact of treatment strategy in survival of patients with idiopathic pulmonary arterial hypertension. Real world evidence from Spanish National Pulmonary Hypertension Registry (REHAP)
2018 · Ana Jaureguizar Oriol, Esther Barbero Herranz, et al. · European Respiratory Journal
P246Diagnostic yield of targeted next generation sequencing panel in pulmonary arterial hypertension and veno-occlusive disease according to the age at diagnosis
2018 · A Rodriguez Chaverri, I Hernandez Gonzalez, et al. · European Heart Journal
Works count: 15
Citation count: 124
H-index: 7
I10-index: 3
Year
Topic
Type